nodes	percent_of_prediction	percent_of_DWPC	metapath
Maraviroc—CCR5—cardiovascular system—Parkinson's disease	0.04	0.232	CbGeAlD
Maraviroc—CCR5—spinal cord—Parkinson's disease	0.0304	0.177	CbGeAlD
Maraviroc—CCR5—IL12-mediated signaling events—HLA-DRA—Parkinson's disease	0.0287	0.0346	CbGpPWpGaD
Maraviroc—CCR5—head—Parkinson's disease	0.0271	0.157	CbGeAlD
Maraviroc—CCR5—nervous system—Parkinson's disease	0.0256	0.149	CbGeAlD
Maraviroc—CCR5—central nervous system—Parkinson's disease	0.0247	0.143	CbGeAlD
Maraviroc—CCR5—HIV Life Cycle—TAF1—Parkinson's disease	0.0236	0.0285	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—VIM—Parkinson's disease	0.0234	0.0283	CbGpPWpGaD
Maraviroc—CYP3A4—Felbamate Metabolism—CYP2E1—Parkinson's disease	0.0216	0.0261	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—GPR37—Parkinson's disease	0.0213	0.0257	CbGpPWpGaD
Maraviroc—CCR5—brain—Parkinson's disease	0.0196	0.114	CbGeAlD
Maraviroc—CCR5—GPCRs, Other—ADORA2A—Parkinson's disease	0.0178	0.0216	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—GPR37—Parkinson's disease	0.0166	0.0201	CbGpPWpGaD
Maraviroc—CCR5—HIV Infection—TAF1—Parkinson's disease	0.0163	0.0197	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Other—DRD3—Parkinson's disease	0.0145	0.0175	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—GPR37—Parkinson's disease	0.0143	0.0172	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—PENK—Parkinson's disease	0.0137	0.0166	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—FASLG—Parkinson's disease	0.0134	0.0162	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Other—HTR7—Parkinson's disease	0.0131	0.0158	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—PDYN—Parkinson's disease	0.0125	0.0151	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—GRM4—Parkinson's disease	0.0122	0.0147	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—PENK—Parkinson's disease	0.0116	0.014	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—GPR37—Parkinson's disease	0.0109	0.0131	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—PDYN—Parkinson's disease	0.0106	0.0128	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.00919	0.0111	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Other—HTR2A—Parkinson's disease	0.00917	0.0111	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—TAC1—Parkinson's disease	0.00846	0.0102	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.0084	0.0102	CbGpPWpGaD
Maraviroc—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—Parkinson's disease	0.0078	0.00942	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.00775	0.00937	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—IL1B—Parkinson's disease	0.00759	0.00917	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—GRM4—Parkinson's disease	0.00738	0.00892	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—HTR1A—Parkinson's disease	0.00725	0.00876	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—PENK—Parkinson's disease	0.007	0.00845	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—DRD3—Parkinson's disease	0.00678	0.00819	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.00673	0.00813	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.00664	0.00803	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.0065	0.00785	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—PDYN—Parkinson's disease	0.0064	0.00773	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.00629	0.0076	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—DGKQ—Parkinson's disease	0.00614	0.00741	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—DRD2—Parkinson's disease	0.00613	0.00741	CbGpPWpGaD
Maraviroc—CYP3A4—Aflatoxin B1 metabolism—GSTM1—Parkinson's disease	0.00601	0.00727	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—GRM5—Parkinson's disease	0.00595	0.00719	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—EDN1—Parkinson's disease	0.00582	0.00703	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.00576	0.00696	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.00569	0.00688	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.00569	0.00688	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.00568	0.00686	CbGpPWpGaD
Maraviroc—CCR5—Disease—VPS35—Parkinson's disease	0.00567	0.00685	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—DGKQ—Parkinson's disease	0.00557	0.00673	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—GPR37—Parkinson's disease	0.00557	0.00673	CbGpPWpGaD
Maraviroc—CYP3A4—Codeine and Morphine Metabolism—ABCB1—Parkinson's disease	0.00557	0.00673	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.00557	0.00673	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—IL1B—Parkinson's disease	0.00549	0.00663	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.00539	0.00651	CbGpPWpGaD
Maraviroc—CCR5—Disease—MCCC1—Parkinson's disease	0.00527	0.00637	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.0051	0.00616	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—ADORA2A—Parkinson's disease	0.00506	0.00611	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—MAPK8—Parkinson's disease	0.00503	0.00608	CbGpPWpGaD
Maraviroc—CCR5—Disease—TALDO1—Parkinson's disease	0.00496	0.00599	CbGpPWpGaD
Maraviroc—CCR5—Disease—OMD—Parkinson's disease	0.00496	0.00599	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.00488	0.00589	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.00488	0.00589	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—GRK5—Parkinson's disease	0.00465	0.00562	CbGpPWpGaD
Maraviroc—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—Parkinson's disease	0.00448	0.00541	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—HTR1A—Parkinson's disease	0.00439	0.0053	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—TAC1—Parkinson's disease	0.00432	0.00522	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—DRD1—Parkinson's disease	0.00424	0.00512	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—GRK5—Parkinson's disease	0.00422	0.0051	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—GRM4—Parkinson's disease	0.00417	0.00504	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—DRD3—Parkinson's disease	0.00411	0.00496	CbGpPWpGaD
Maraviroc—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.0041	0.00495	CbGpPWpGaD
Maraviroc—CCR5—Disease—FBP1—Parkinson's disease	0.004	0.00483	CbGpPWpGaD
Maraviroc—CCR5—Disease—TAF1—Parkinson's disease	0.004	0.00483	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00399	0.00482	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—VPS35—Parkinson's disease	0.00397	0.0048	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—PENK—Parkinson's disease	0.00395	0.00478	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.0039	0.00472	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—GRM4—Parkinson's disease	0.00379	0.00458	CbGpPWpGaD
Maraviroc—CYP3A4—Xenobiotics—CYP2D6—Parkinson's disease	0.00375	0.00453	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—DRD2—Parkinson's disease	0.00371	0.00449	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—HTR7—Parkinson's disease	0.00371	0.00449	CbGpPWpGaD
Maraviroc—CYP3A4—Estrogen metabolism—NQO1—Parkinson's disease	0.00369	0.00445	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—PDYN—Parkinson's disease	0.00362	0.00437	CbGpPWpGaD
Maraviroc—CYP3A4—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.0036	0.00435	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—PENK—Parkinson's disease	0.00359	0.00434	CbGpPWpGaD
Maraviroc—CYP3A4—Xenobiotics—CYP2E1—Parkinson's disease	0.00343	0.00414	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00341	0.00413	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—GRM5—Parkinson's disease	0.00336	0.00406	CbGpPWpGaD
Maraviroc—CYP3A4—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.00329	0.00398	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—GPR37—Parkinson's disease	0.00329	0.00398	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—DGKQ—Parkinson's disease	0.00329	0.00398	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—PDYN—Parkinson's disease	0.00328	0.00397	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—IL6—Parkinson's disease	0.00321	0.00388	CbGpPWpGaD
Maraviroc—CCR5—Disease—SNCA—Parkinson's disease	0.00319	0.00386	CbGpPWpGaD
Maraviroc—CCR5—Disease—RPL6—Parkinson's disease	0.00319	0.00386	CbGpPWpGaD
Maraviroc—CYP3A4—Estrogen metabolism—COMT—Parkinson's disease	0.00309	0.00373	CbGpPWpGaD
Maraviroc—CYP3A4—Tryptophan metabolism—DDC—Parkinson's disease	0.00308	0.00372	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—GRM5—Parkinson's disease	0.00305	0.00369	CbGpPWpGaD
Maraviroc—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—Parkinson's disease	0.00305	0.00368	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00301	0.00364	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—EDN1—Parkinson's disease	0.00297	0.00359	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00286	0.00345	CbGpPWpGaD
Maraviroc—CYP3A4—Estrogen metabolism—GSTM1—Parkinson's disease	0.00282	0.00341	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—RIT2—Parkinson's disease	0.00263	0.00318	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—HTR2A—Parkinson's disease	0.0026	0.00314	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—ADORA2A—Parkinson's disease	0.0026	0.00314	CbGpPWpGaD
Maraviroc—CYP3A4—Tryptophan metabolism—MAOB—Parkinson's disease	0.00259	0.00313	CbGpPWpGaD
Maraviroc—CYP3A4—nervous system—Parkinson's disease	0.00259	0.015	CbGeAlD
Maraviroc—CCR5—Signaling Pathways—GRK5—Parkinson's disease	0.00249	0.00301	CbGpPWpGaD
Maraviroc—CYP3A4—central nervous system—Parkinson's disease	0.00249	0.0144	CbGeAlD
Maraviroc—CCR5—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00248	0.003	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—TAC1—Parkinson's disease	0.00244	0.00295	CbGpPWpGaD
Maraviroc—CCR5—Disease—RPL23A—Parkinson's disease	0.00242	0.00293	CbGpPWpGaD
Maraviroc—CCR5—Disease—RPL14—Parkinson's disease	0.00242	0.00293	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—DRD1—Parkinson's disease	0.0024	0.00289	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—DRD3—Parkinson's disease	0.00232	0.0028	CbGpPWpGaD
Maraviroc—CCR5—Disease—RPS8—Parkinson's disease	0.00226	0.00273	CbGpPWpGaD
Maraviroc—CCR5—Disease—FGF20—Parkinson's disease	0.00226	0.00273	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—HTR1A—Parkinson's disease	0.00225	0.00272	CbGpPWpGaD
Maraviroc—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.00224	0.00271	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—GRM4—Parkinson's disease	0.00224	0.0027	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—TAC1—Parkinson's disease	0.00222	0.00268	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—DRD1—Parkinson's disease	0.00218	0.00263	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.00217	0.00262	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PENK—Parkinson's disease	0.00212	0.00256	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—MAG—Parkinson's disease	0.00212	0.00256	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—DRD3—Parkinson's disease	0.00211	0.00255	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—DRD2—Parkinson's disease	0.0021	0.00254	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—HTR7—Parkinson's disease	0.0021	0.00254	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—ADRBK1—Parkinson's disease	0.00197	0.00238	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PDYN—Parkinson's disease	0.00194	0.00234	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—HTR7—Parkinson's disease	0.00191	0.0023	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—DRD2—Parkinson's disease	0.00191	0.0023	CbGpPWpGaD
Maraviroc—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.00184	0.00222	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—GFAP—Parkinson's disease	0.00182	0.0022	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—GRM5—Parkinson's disease	0.0018	0.00218	CbGpPWpGaD
Maraviroc—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.00176	0.00213	CbGpPWpGaD
Maraviroc—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.00175	0.00211	CbGpPWpGaD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.0017	0.00205	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—EDN1—Parkinson's disease	0.00168	0.00203	CbGpPWpGaD
Maraviroc—CCR5—Disease—ADRBK1—Parkinson's disease	0.00166	0.00201	CbGpPWpGaD
Maraviroc—CCR5—Disease—HSPA1A—Parkinson's disease	0.00165	0.00199	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—FGF20—Parkinson's disease	0.00158	0.00191	CbGpPWpGaD
Maraviroc—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.00156	0.00188	CbGpPWpGaD
Maraviroc—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.00153	0.00185	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—ADORA2A—Parkinson's disease	0.00153	0.00185	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—EDN1—Parkinson's disease	0.00153	0.00184	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—HTR2A—Parkinson's disease	0.00147	0.00178	CbGpPWpGaD
Maraviroc—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.00142	0.00172	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—INSR—Parkinson's disease	0.00142	0.00171	CbGpPWpGaD
Maraviroc—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.0014	0.0017	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—FGB—Parkinson's disease	0.00134	0.00162	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—HTR2A—Parkinson's disease	0.00133	0.00161	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—HTR1A—Parkinson's disease	0.00133	0.00161	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—TAC1—Parkinson's disease	0.00131	0.00158	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—DRD1—Parkinson's disease	0.00129	0.00155	CbGpPWpGaD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.00126	0.00152	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—DRD3—Parkinson's disease	0.00124	0.0015	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—ADRBK1—Parkinson's disease	0.00116	0.0014	CbGpPWpGaD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00115	0.00139	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—DRD2—Parkinson's disease	0.00113	0.00136	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—HTR7—Parkinson's disease	0.00113	0.00136	CbGpPWpGaD
Maraviroc—CCR5—Disease—MTHFR—Parkinson's disease	0.00112	0.00136	CbGpPWpGaD
Maraviroc—CCR5—Disease—APOE—Parkinson's disease	0.00105	0.00126	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.00101	0.00122	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000997	0.00121	CbGpPWpGaD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000949	0.00115	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IGF2—Parkinson's disease	0.000943	0.00114	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IGF1R—Parkinson's disease	0.000912	0.0011	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.000901	0.00109	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—EDN1—Parkinson's disease	0.000901	0.00109	CbGpPWpGaD
Maraviroc—CCR5—Disease—INS—Parkinson's disease	0.000894	0.00108	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—NGF—Parkinson's disease	0.000828	0.001	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—HTR2A—Parkinson's disease	0.000788	0.000953	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—APOE—Parkinson's disease	0.000733	0.000886	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.00067	0.000809	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000661	0.000798	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—INS—Parkinson's disease	0.000626	0.000757	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	0.000613	0.00074	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000604	0.00073	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—COMT—Parkinson's disease	0.000508	0.000613	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	0.000505	0.00061	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	0.000504	0.000609	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	0.000501	0.000605	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000498	0.000602	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CASP3—Parkinson's disease	0.000466	0.000563	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	0.000464	0.000561	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—IL6—Parkinson's disease	0.000463	0.00056	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000458	0.000553	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—MAPK8—Parkinson's disease	0.000428	0.000518	CbGpPWpGaD
Maraviroc—CCR5—Disease—IL6—Parkinson's disease	0.000391	0.000472	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ND3—Parkinson's disease	0.000329	0.000398	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—MCCC1—Parkinson's disease	0.000329	0.000398	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—TALDO1—Parkinson's disease	0.000309	0.000374	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—OMD—Parkinson's disease	0.000309	0.000374	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	0.000293	0.000355	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GCH1—Parkinson's disease	0.00028	0.000338	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IL6—Parkinson's disease	0.000274	0.000331	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—FBP1—Parkinson's disease	0.000249	0.000301	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—DBH—Parkinson's disease	0.000249	0.000301	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GBA—Parkinson's disease	0.000249	0.000301	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—DDC—Parkinson's disease	0.000183	0.000221	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GSTA4—Parkinson's disease	0.000173	0.000209	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	0.000156	0.000188	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—MAOB—Parkinson's disease	0.000154	0.000186	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	0.000115	0.000138	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CTGF—Parkinson's disease	0.000112	0.000136	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	0.000105	0.000127	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—NQO1—Parkinson's disease	0.000104	0.000125	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—TH—Parkinson's disease	0.000102	0.000123	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CYCS—Parkinson's disease	9.8e-05	0.000118	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—COMT—Parkinson's disease	8.68e-05	0.000105	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GSTP1—Parkinson's disease	8.64e-05	0.000104	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—MAOA—Parkinson's disease	8.62e-05	0.000104	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—HMOX1—Parkinson's disease	8.52e-05	0.000103	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ABCB1—Parkinson's disease	8.18e-05	9.88e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GSTM1—Parkinson's disease	7.94e-05	9.59e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GPX1—Parkinson's disease	7.6e-05	9.19e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—MTHFR—Parkinson's disease	7.02e-05	8.48e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—APOE—Parkinson's disease	6.53e-05	7.89e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—INS—Parkinson's disease	5.58e-05	6.74e-05	CbGpPWpGaD
